so we expect there to be more growth coming from these complex injectables that we will add to the portfolio," Piramal said. ...

Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.

Stock Market Today: Piramal Enterprises share price gained more than 8% during the the intraday trades on Tuesday. Piramal Enterprises announced that it will be receiving post $140 million deal ...

The pharmaceutical company's consolidated net profit tumbled 63.6% to Rs 3.68 crore despite of 12.54% increase in revenue from operations to Rs 2,204.22 crore in Q3 FY25 over Q3 FY24.